We serve Chemical Name:(4-methylmorpholin-3-yl)methanamine CAS:68431-71-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(4-methylmorpholin-3-yl)methanamine
CAS.NO:68431-71-0
Synonyms:BH2075;4-Methyl-3-(aminomethyl)morpholine;4-Methyl-3-morpholinemethanamine
Molecular Formula:C6H14N2O
Molecular Weight:130.18800
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:188.662ºC at 760 mmHg
Density:0.977g/cm3
Index of Refraction:1.461
PSA:38.49000
Exact Mass:130.11100
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like BH2075 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methyl-3-morpholinemethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Methyl-3-(aminomethyl)morpholine Use and application,4-Methyl-3-morpholinemethanamine technical grade,usp/ep/jp grade.
Related News: Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. (4-methylmorpholin-3-yl)methanamine manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. (4-methylmorpholin-3-yl)methanamine supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. (4-methylmorpholin-3-yl)methanamine vendor The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). (4-methylmorpholin-3-yl)methanamine factory There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said.
